Replies to post #62860 on Cytogenix (fka CYGX)

[Paulness]

Share holder value is the main theme of all CYGX press releases , this stock can hit the $4.00 per share mark with good news, and $40.00 per share with a profitable product . Look at DNDN ,look at the shares out for DNDN ,now look at the product ,it's a one horse pony show . Unlike Cytogenix with a multi product plan .